BRPI0914302A2 - intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo - Google Patents
intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmoInfo
- Publication number
- BRPI0914302A2 BRPI0914302A2 BRPI0914302A BRPI0914302A BRPI0914302A2 BR PI0914302 A2 BRPI0914302 A2 BR PI0914302A2 BR PI0914302 A BRPI0914302 A BR PI0914302A BR PI0914302 A BRPI0914302 A BR PI0914302A BR PI0914302 A2 BRPI0914302 A2 BR PI0914302A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- same
- percutaneous absorption
- transdermal enhancer
- enhancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008162730 | 2008-06-23 | ||
PCT/JP2009/002837 WO2009157173A1 (ja) | 2008-06-23 | 2009-06-22 | 経皮吸収促進剤及びこれを用いた経皮投与製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0914302A2 true BRPI0914302A2 (pt) | 2015-10-13 |
Family
ID=41444246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0914302A BRPI0914302A2 (pt) | 2008-06-23 | 2009-06-22 | intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo |
Country Status (9)
Country | Link |
---|---|
US (1) | US8771724B2 (pt) |
EP (1) | EP2298352B1 (pt) |
JP (2) | JP5656221B2 (pt) |
KR (1) | KR20110036709A (pt) |
CN (1) | CN102065900B (pt) |
BR (1) | BRPI0914302A2 (pt) |
CA (1) | CA2728952C (pt) |
RU (1) | RU2504363C2 (pt) |
WO (1) | WO2009157173A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488900B (zh) * | 2011-12-06 | 2013-09-25 | 沈阳药科大学 | 癸酸二乙醇酰胺及类似物的应用 |
EP2938391B1 (en) * | 2012-12-28 | 2022-07-27 | Teikoku Seiyaku Co., Ltd. | Extended buprenorphine transdermal delivery compositions |
US10292955B2 (en) | 2013-04-04 | 2019-05-21 | Hyundai Pharm Co., Ltd. | Composition for external use preparation with improved transdermal permeability |
CN111195242B (zh) * | 2018-11-16 | 2022-10-25 | 得生制药股份有限公司 | 经皮吸收贴片 |
CA3147431A1 (en) | 2019-07-16 | 2021-01-21 | Donaghys Limited | Transdermal solvent system and methods of use |
CN112933035A (zh) * | 2021-01-27 | 2021-06-11 | 杭州医学院 | 一种生物可溶性微针贴片及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0617316B2 (ja) * | 1987-03-06 | 1994-03-09 | 積水化学工業株式会社 | 経皮吸収製剤 |
US5260292A (en) * | 1991-03-05 | 1993-11-09 | Marvin S. Towsend | Topical treatment of acne with aminopenicillins |
JPH06219947A (ja) * | 1993-01-26 | 1994-08-09 | Kinki Univ | 経皮投与製剤 |
JPH0717851A (ja) | 1993-07-02 | 1995-01-20 | Teijin Ltd | (メタ)アクリル酸エステル系粘着剤を用いた薬剤含有貼付剤 |
JPH10182455A (ja) | 1996-12-24 | 1998-07-07 | Teisan Seiyaku Kk | メラトニン含有貼付剤 |
FR2768630B1 (fr) | 1997-09-22 | 2000-08-04 | Ulice Sa | Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires |
US5958447A (en) * | 1998-03-17 | 1999-09-28 | Plc Holding, L.L.C. | Adhesive matrix type transdermal patch and method of manufacturing same |
EP1221315A4 (en) * | 1999-10-13 | 2007-12-12 | Senju Pharma Co | ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING |
AR036237A1 (es) * | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
EP1863511A2 (en) | 2005-02-23 | 2007-12-12 | UAB Research Foundation | Alkyl-glycoside enhanced vaccination |
DE102005031482A1 (de) * | 2005-07-04 | 2007-01-18 | Henkel Kgaa | Hautaufhellende Zusammensetzungen mit verbesserter Wirkung |
JP5130203B2 (ja) | 2006-04-28 | 2013-01-30 | ライオン株式会社 | 非水系粘着剤組成物、貼付剤および貼付剤の製造方法 |
US20070259029A1 (en) | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
US9918934B2 (en) * | 2006-12-12 | 2018-03-20 | Edgar Joel Acosta-Zara | Linker-based lecithin microemulsion delivery vehicles |
-
2009
- 2009-06-22 RU RU2011102454/15A patent/RU2504363C2/ru not_active IP Right Cessation
- 2009-06-22 EP EP09769883.1A patent/EP2298352B1/en not_active Not-in-force
- 2009-06-22 US US13/000,635 patent/US8771724B2/en not_active Expired - Fee Related
- 2009-06-22 KR KR1020107028798A patent/KR20110036709A/ko active IP Right Grant
- 2009-06-22 BR BRPI0914302A patent/BRPI0914302A2/pt not_active IP Right Cessation
- 2009-06-22 CA CA2728952A patent/CA2728952C/en not_active Expired - Fee Related
- 2009-06-22 WO PCT/JP2009/002837 patent/WO2009157173A1/ja active Application Filing
- 2009-06-22 JP JP2010517749A patent/JP5656221B2/ja active Active
- 2009-06-22 CN CN2009801239816A patent/CN102065900B/zh not_active Expired - Fee Related
-
2014
- 2014-09-24 JP JP2014193410A patent/JP5892396B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CN102065900B (zh) | 2013-09-25 |
CN102065900A (zh) | 2011-05-18 |
JP5656221B2 (ja) | 2015-01-21 |
KR20110036709A (ko) | 2011-04-08 |
JPWO2009157173A1 (ja) | 2011-12-08 |
EP2298352A1 (en) | 2011-03-23 |
CA2728952A1 (en) | 2009-12-30 |
JP2014237728A (ja) | 2014-12-18 |
EP2298352B1 (en) | 2015-01-14 |
RU2504363C2 (ru) | 2014-01-20 |
WO2009157173A1 (ja) | 2009-12-30 |
US8771724B2 (en) | 2014-07-08 |
RU2011102454A (ru) | 2012-07-27 |
EP2298352A4 (en) | 2013-12-11 |
CA2728952C (en) | 2015-06-09 |
US20110104241A1 (en) | 2011-05-05 |
JP5892396B2 (ja) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0907453A2 (pt) | Compostos, uso e preparação dos mesmos | |
BRPI0815588A2 (pt) | Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano | |
BRPI0914682A2 (pt) | compostos de heteroarila e usos dos mesmos | |
BRPI0909469A2 (pt) | compostos de oximetileno de arila e usos dos mesmos | |
BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
BRPI0923725A2 (pt) | "compostos absorventes de uv trifuncionais e uso dos mesmos". | |
BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
BRPI0908853A2 (pt) | composto oligopeptídicos e seus usos | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
EP1844773A4 (en) | PREPARATION FOR PERCUTANEOUS ABSORPTION | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0914536A2 (pt) | tiadiazoliloxifenilamidinas e o uso destas como fungicidas | |
EP1992363A4 (en) | PREPARATION FOR TRANSDERMAL ABSORPTION | |
BRPI0907365A2 (pt) | Composição antimicrobiana e uso | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
DK2318378T3 (da) | Quinazolin-derivater | |
BRPI0807905A2 (pt) | Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona. | |
DK2325662T3 (da) | Multi-indlæsnings- og multi-udlæsningsanalysator | |
DE502008000740D1 (de) | Rollosystem | |
BRPI0914302A2 (pt) | intensificador de absorção percutânea e preparação e transdérmica utilizando o mesmo | |
PL2235013T3 (pl) | Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach | |
BRPI0907043A2 (pt) | Composição, uso do composto, e, composto | |
BRPI0810047A2 (pt) | Compostos e seus usos 707 | |
BRPI0911719A8 (pt) | composição coccidiocida e seu uso | |
BR112012002293A2 (pt) | composto, composição farmacêutica, e, uso do composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |